Guevarra, Chezrylle Khyle I.
HRN: 13-38-61 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/03/2024
CEFUROXIME 750MG (VIAL)
10/03/2024
10/10/2024
INTRAVENOUS
580 Mg
Every 8 Hours
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes